by Zoe Hogue | Jan 29, 2026 | Blog
Introduction In 2026, cancer treatment has reached a critical turning point.While chemotherapy and radiation remain foundational, they often act as blunt instruments. Healthy tissue suffers alongside the tumor. Peptide-based cancer therapeutics are changing that...
by Zoe Hogue | Jan 29, 2026 | Blog
Introduction In 2026, the obesity conversation officially changed.The focus shifted from willpower to biology. At the center of this shift is GLP-1 (Glucagon-Like Peptide-1). Originally identified as a gut hormone, GLP-1 now powers the most in-demand weight-loss...
by Zoe Hogue | Jan 29, 2026 | Blog
The Two-Tiered Peptide Market Structure The peptide therapeutics market follows a clear two-tier structure.Innovative (branded) peptides, protected by patents, command premium pricing and dominate market share. Generic and biosimilar peptides enter after...
by Zoe Hogue | Jan 29, 2026 | Uncategorized
Innovative vs Generic Peptide Therapeutics The Two-Tiered Market Structure The peptide therapeutics market operates within a distinctive dual framework: innovative (branded) peptides protected by patents command premium pricing and dominant market share, while...
by Zoe Hogue | Jan 29, 2026 | Blog
Global Peptide Therapeutics Market Size: $260B by 2030 Market Trajectory: From $117B to $260B The global peptide therapeutics market stands poised for remarkable expansion, with valuations projected to more than double from $117.26 billion in 2024 to $260.25 billion...
